{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_6979"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_6979","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"Outpatient follow-up visits and the risk of all-cause 30-day hospital readmissions for patients discharged following a cardiovascular or COPD related event : a systematic review and meta-analysis","abstract":"Hospital readmissions are important as they are costly, are associated with high mortality, morbidity and an increased risk of long-term care, and are important as readmissions are now included in Pay-for-Performance (P4P) programs (1-3). One potential mechanism to reduce readmission is through outpatient follow-up visits with a physician after initial discharge (4). This review seeks to understand the effect outpatient follow-up visits have on all-cause 30-day readmissions for patients with an initial discharge of Acute Myocardial Infarction (AMI), heart failure, Chronic Obstructive Pulmonary Disease (COPD) or an acute stroke event. We conducted a systematic review and meta-analysis of observational studies, searching the PubMed and CINAHL databases. The search consisted of articles published in the United States over a 10 year period 2007 through 2017. We calculated relative risk (RR) and 95% confidence intervals for each outcome and assessed heterogeneity using the I2 and Q-statistics. From 573 hits, we identified 10 eligible studies. The pooled RR from the six patient-level studies found that outpatient follow-up visits reduced the risk of readmission by 13% (RR= 0.87; 95% CI 0.77-0.97, p= 0.014). However, the I2 statistic was 65.5% and the Q-statistic p-value was 0.05, indicating that there is a moderate to substantial amount of heterogeneity. Hospital-level studies were not included in the analysis. Although some evidence exists for the benefit of outpatient follow-up visits with a physician, additional evidence is needed in order to quantify the impact of outpatient follow-up visits to reduce 30-day readmissions. -- Abstract.","abstract_html":"Hospital readmissions are important as they are costly, are associated with high mortality, morbidity and an increased risk of long-term care, and are important as readmissions are now included in Pay-for-Performance (P4P) programs (1-3). One potential mechanism to reduce readmission is through outpatient follow-up visits with a physician after initial discharge (4). This review seeks to understand the effect outpatient follow-up visits have on all-cause 30-day readmissions for patients with an initial discharge of Acute Myocardial Infarction (AMI), heart failure, Chronic Obstructive Pulmonary Disease (COPD) or an acute stroke event. We conducted a systematic review and meta-analysis of observational studies, searching the PubMed and CINAHL databases. The search consisted of articles published in the United States over a 10 year period 2007 through 2017. We calculated relative risk (RR) and 95% confidence intervals for each outcome and assessed heterogeneity using the I2 and Q-statistics. From 573 hits, we identified 10 eligible studies. The pooled RR from the six patient-level studies found that outpatient follow-up visits reduced the risk of readmission by 13% (RR= 0.87; 95% CI 0.77-0.97, p= 0.014). However, the I2 statistic was 65.5% and the Q-statistic p-value was 0.05, indicating that there is a moderate to substantial amount of heterogeneity. Hospital-level studies were not included in the analysis. Although some evidence exists for the benefit of outpatient follow-up visits with a physician, additional evidence is needed in order to quantify the impact of outpatient follow-up visits to reduce 30-day readmissions. -- Abstract.","abstract_has_math":false,"creators":["Reichle, Garrett"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Reeves, Mat","Talge, Nicole","Barondess, David"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2018,"date_issued":"2018","date_published":"2018","updated_at":"2026-11-18T19:00:56Z","subjects":["Hospitals--Outpatient services","Hospitals--Cost control","Hospitals--After care","Hospitals--Admission and discharge","Ambulatory medical care"],"languages":["English"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:6979","isbn:9780355598100","isbn:0355598108","oclc:1078987962","umi:10743226","local:Reichle_grad.msu_0128N_15841"],"render_values":[{"text":"etd:6979","href":null,"code":true},{"text":"isbn:9780355598100","href":null,"code":true},{"text":"isbn:0355598108","href":null,"code":true},{"text":"oclc:1078987962","href":null,"code":true},{"text":"umi:10743226","href":null,"code":true},{"text":"local:Reichle_grad.msu_0128N_15841","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_6979","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Reeves, Mat","Talge, Nicole","Barondess, David"]},{"key":"dc:creator","label":"Author","values":["Reichle, Garrett"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:coverage","label":"Dc Coverage","values":["United States"]},{"key":"dc:date","label":"Dc Date","values":["2018"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["Text","Theses"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Hospitals--Outpatient services","Hospitals--Cost control","Hospitals--After care","Hospitals--Admission and discharge","Ambulatory medical care"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:6979","isbn:9780355598100","isbn:0355598108","oclc:1078987962","umi:10743226","local:Reichle_grad.msu_0128N_15841"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Hospital readmissions are important as they are costly, are associated with high mortality, morbidity and an increased risk of long-term care, and are important as readmissions are now included in Pay-for-Performance (P4P) programs (1-3). One potential mechanism to reduce readmission is through outpatient follow-up visits with a physician after initial discharge (4). This review seeks to understand the effect outpatient follow-up visits have on all-cause 30-day readmissions for patients with an initial discharge of Acute Myocardial Infarction (AMI), heart failure, Chronic Obstructive Pulmonary Disease (COPD) or an acute stroke event. We conducted a systematic review and meta-analysis of observational studies, searching the PubMed and CINAHL databases. The search consisted of articles published in the United States over a 10 year period 2007 through 2017. We calculated relative risk (RR) and 95% confidence intervals for each outcome and assessed heterogeneity using the I2 and Q-statistics. From 573 hits, we identified 10 eligible studies. The pooled RR from the six patient-level studies found that outpatient follow-up visits reduced the risk of readmission by 13% (RR= 0.87; 95% CI 0.77-0.97, p= 0.014). However, the I2 statistic was 65.5% and the Q-statistic p-value was 0.05, indicating that there is a moderate to substantial amount of heterogeneity. Hospital-level studies were not included in the analysis. Although some evidence exists for the benefit of outpatient follow-up visits with a physician, additional evidence is needed in order to quantify the impact of outpatient follow-up visits to reduce 30-day readmissions. -- Abstract.","(M.S.)--Michigan State University. Epidemiology, 2018","Includes bibliographical references (pages 98-106)"]},{"key":"dc:format","label":"Dc Format","values":["ix, 106 pages","application/pdf"]},{"key":"dc:title","label":"Title","values":["Outpatient follow-up visits and the risk of all-cause 30-day hospital readmissions for patients discharged following a cardiovascular or COPD related event : a systematic review and meta-analysis"]}]}],"canonical_facts":{"dc:contributor":["Reeves, Mat","Talge, Nicole","Barondess, David"],"dc:coverage":["United States"],"dc:creator":["Reichle, Garrett"],"dc:date":["2018"],"dc:description":["Hospital readmissions are important as they are costly, are associated with high mortality, morbidity and an increased risk of long-term care, and are important as readmissions are now included in Pay-for-Performance (P4P) programs (1-3). One potential mechanism to reduce readmission is through outpatient follow-up visits with a physician after initial discharge (4). This review seeks to understand the effect outpatient follow-up visits have on all-cause 30-day readmissions for patients with an initial discharge of Acute Myocardial Infarction (AMI), heart failure, Chronic Obstructive Pulmonary Disease (COPD) or an acute stroke event. We conducted a systematic review and meta-analysis of observational studies, searching the PubMed and CINAHL databases. The search consisted of articles published in the United States over a 10 year period 2007 through 2017. We calculated relative risk (RR) and 95% confidence intervals for each outcome and assessed heterogeneity using the I2 and Q-statistics. From 573 hits, we identified 10 eligible studies. The pooled RR from the six patient-level studies found that outpatient follow-up visits reduced the risk of readmission by 13% (RR= 0.87; 95% CI 0.77-0.97, p= 0.014). However, the I2 statistic was 65.5% and the Q-statistic p-value was 0.05, indicating that there is a moderate to substantial amount of heterogeneity. Hospital-level studies were not included in the analysis. Although some evidence exists for the benefit of outpatient follow-up visits with a physician, additional evidence is needed in order to quantify the impact of outpatient follow-up visits to reduce 30-day readmissions. -- Abstract.","(M.S.)--Michigan State University. Epidemiology, 2018","Includes bibliographical references (pages 98-106)"],"dc:format":["ix, 106 pages","application/pdf"],"dc:identifier":["etd:6979","isbn:9780355598100","isbn:0355598108","oclc:1078987962","umi:10743226","local:Reichle_grad.msu_0128N_15841"],"dc:language":["English"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Hospitals--Outpatient services","Hospitals--Cost control","Hospitals--After care","Hospitals--Admission and discharge","Ambulatory medical care"],"dc:title":["Outpatient follow-up visits and the risk of all-cause 30-day hospital readmissions for patients discharged following a cardiovascular or COPD related event : a systematic review and meta-analysis"],"dc:type":["Text","Theses"]},"updated_at":"2026-11-18T19:00:56Z"}